Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority claimed from PCT/DK1997/000172external-prioritypatent/WO1997039638A1/en
Publication of CA2251798A1publicationCriticalpatent/CA2251798A1/en
Application grantedgrantedCritical
Publication of CA2251798CpublicationCriticalpatent/CA2251798C/en
The present invention relates to the combined use, simultaneous or sequential, of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II in animal feed. It also relates to animal feed and animal feed additives comprising such combination of xylanolytic enzymes.
SUBSTITUTED-2-AMINO-1,2,3,4-TETRAHYDRODIBENZOFURANS AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS USEFUL AS 5-HT1F AGONISTS IN MAMMALS, PHARMACEUTICAL FORMULATION